Skip to content Search the desk⌘ Ctrl K Agent Sign in S Sotera Health Co
S SHC Sotera Health Co
S SHC Sotera Health Co
Earnings When Sotera Health Co reports, what it reported each quarter, and how the stock took the results.
27 quarters. Mar 31, 2020 to Sep 30, 2026. USD.
Next results · Q4 2026 Projected
Feb 23, before the open
Tue, Feb 23, 2027 in 93 days
Projected from its last 8 releases. The company has not named the day yet.
Quarter Q4 2026 · Ends about Dec 31, 2026
10-K window Feb 24 – Mar 4 Quarter by quarter 3 years 5 years 10 years
Revenue Net income EPS Gross profit Operating income Operating cash flow Free cash flow
Q3 2026 $ 3 2 4 . 8 9 M $324.89M +4.4% vs Q3 2025
Revenue $324.89M +4.4%
Net income $58.39M +20.6%
EPS $0.20 +17.6% Q2 2026 Aug 6, 2026, before the openSotera Health Co · CIK 1822479 · Engraved from SEC EDGAR
Revenue $321.38M +9.2%
Net income $53.64M +573.7%
EPS $0.19 +533.3%
Revenue $280.05M +10.0%
Net income $26.59M N/M
EPS $0.09 N/M
Revenue $303.44M +4.6%
Net income $34.85M +182.8%
EPS — —
Results day Typical move ±4.8% A typical move of 4.8% either way
Up after 5 of 12, down after 7.
+1.7% −11.0% +3.7%
When it reports
Usual day Varies
After quarter end 34 to 55 days
10-Q filed 34 to 37 days over its last 8
10-K filed 58 to 60 days over its last 6 ended Sep 30, 2024 · filed Nov 5, 2024 · 36 d ended Dec 31, 2024 · filed Feb 27, 2025 · 58 d ended Mar 31, 2025 · filed May 1, 2025 · 31 d ended Jun 30, 2025 · filed Aug 8, 2025 · 39 d ended Sep 30, 2025 · filed Nov 4, 2025 · 35 d ended Dec 31, 2025 · filed Feb 24, 2026 · 55 d FY 2026 Q3 2026 Sep 30, 2026 Nov 3, 2026 · pre-market Nov 3, 2026 34 d 10-Q $324.89M +4.4% $0.20 9.7% Q2 2026 Jun 30, 2026 Aug 6, 2026 · pre-market Aug 6, 2026 37 d 10-Q $321.38M +9.2% $0.19 +5.0% Q1 2026 Mar 31, 2026 May 5, 2026 · pre-market May 5, 2026 35 d 10-Q $280.05M +10.0% $0.09 0.2%
FY 2025 Q4 2025 derived Dec 31, 2025 Feb 24, 2026 · pre-market Feb 24, 2026 55 d 10-K $303.44M +4.6% — 4.5% Q3 2025 Sep 30, 2025 Nov 4, 2025 · pre-market Nov 4, 2025 35 d 10-Q $311.31M +9.1% $0.17 1.2% Q2 2025 Jun 30, 2025 Aug 8, 2025 · pre-market Aug 8, 2025 39 d 10-Q $294.34M +6.4% $0.03 +24.3% Q1 2025 Mar 31, 2025 May 1, 2025 · pre-market May 1, 2025 31 d 10-Q $254.52M +2.6% -$0.05 +5.2%
FY 2024 Q4 2024 derived Dec 31, 2024 Feb 27, 2025 · pre-market Feb 27, 2025 58 d 10-K $290.20M −6.5% — 9.9% Q3 2024 Sep 30, 2024 Nov 5, 2024 · pre-market Nov 5, 2024 36 d 10-Q $285.47M +8.5% $0.06 2.5% Q2 2024 Jun 30, 2024 Aug 5, 2024 · pre-market Aug 5, 2024 36 d 10-Q $276.59M +8.3% $0.03 +3.7% Q1 2024 Mar 31, 2024 May 2, 2024 · pre-market May 2, 2024 32 d 10-Q $248.18M +12.5% $0.02 —
FY 2023 Q4 2023 derived Dec 31, 2023 Feb 27, 2024 · pre-market Feb 27, 2024 58 d 10-K $310.24M +23.3% — 11.0% Q3 2023 Sep 30, 2023 Nov 1, 2023 · pre-market Nov 1, 2023 32 d 10-Q $263.18M +5.8% -$0.05 +1.7% Q2 2023 Jun 30, 2023 Aug 3, 2023 · pre-market Aug 3, 2023 34 d 10-Q $255.28M −4.3% $0.08 9.5% Q1 2023 Mar 31, 2023 May 3, 2023 · pre-market May 3, 2023 33 d 10-Q $220.59M −6.8% $0.01 7.7%
FY 2022 Q4 2022 derived Dec 31, 2022 Feb 28, 2023 · pre-market Feb 28, 2023 59 d 10-K $251.59M +4.3% — 2.8% Q3 2022 Sep 30, 2022 Nov 2, 2022 · pre-market Nov 2, 2022 33 d 10-Q $248.70M +10.0% $0.09 9.0% Q2 2022 Jun 30, 2022 Aug 4, 2022 · pre-market Aug 4, 2022 35 d 10-Q $266.64M +5.8% $0.11 +1.3% Q1 2022 Mar 31, 2022 May 5, 2022 · pre-market May 5, 2022 35 d 10-Q $236.75M +11.6% $0.11 +1.3%
FY 2021 Q4 2021 derived Dec 31, 2021 Mar 1, 2022 · pre-market Mar 1, 2022 60 d 10-K $241.25M +11.3% — — Q3 2021 Sep 30, 2021 Nov 10, 2021 · pre-market Nov 10, 2021 41 d 10-Q $226.16M +13.1% $0.10 15.5% Q2 2021 Jun 30, 2021 Aug 12, 2021 · pre-market Aug 12, 2021 43 d 10-Q $251.92M +18.2% $0.15 — Q1 2021 Mar 31, 2021 May 13, 2021 · pre-market May 13, 2021 43 d 10-Q $212.15M +12.7% $0.04 3.4%
FY 2020 Q4 2020 derived Dec 31, 2020 Mar 9, 2021 · pre-market Mar 9, 2021 68 d 10-K $216.85M — — +6.7% Q3 2020 Sep 30, 2020 — — — — $200.03M — $0.00 — Q2 2020 Jun 30, 2020 — — — — $213.09M — $0.03 — Q1 2020 Mar 31, 2020 — — — — $188.20M — -$0.01 —
Earlier years, FY 2020 to FY 2023 The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
10-Q
May 5, 2026
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
Year over year, last four quarters
Revenue $303.44M Revenue, change from a year earlier: Q3 2026 +4.4%, Q2 2026 +9.2%, Q1 2026 +10.0%, Q4 2025 +4.6% +4.6% +10.0% +9.2% +4.4%
Net income $34.85M Net income, change from a year earlier: Q3 2026 +20.6%, Q2 2026 +573.7%, Q1 2026 n/m, Q4 2025 +182.8% +182.8% n/m +573.7% +20.6%
EPS — EPS, change from a year earlier: Q3 2026 +17.6%, Q2 2026 +533.3%, Q1 2026 n/m, Q3 2025 +183.3% +183.3% n/m +533.3% +17.6% 9.7% by the close of Nov 3
Thaler Research Engraved from SEC EDGAR © 2026 Thaler. All rights reserved. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
+5.0% by the close of Aug 6
ended Mar 31, 2026 · filed May 5, 2026 · 35 d ended Jun 30, 2026 · filed Aug 6, 2026 · 37 d ended Sep 30, 2026 · filed Nov 3, 2026 · 34 d window Feb 24 – Mar 4 · projected The stock’s move from the last close before each release to the first close after it, over the last 12 releases. Largest: +24.3% after Q2 2025.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Provenance Data status and checks